Can You Reverse Aging? The Science of Longevity

1. Lifespan, healthspan, and what aging actually is

2. Biological age tests: what they measure and what they miss

note

Common biological age tests

Epigenetic clocks

Measure DNA methylation patterns. Examples include Horvath clock, PhenoAge, and GrimAge.

Blood-based panels

May combine inflammation, lipids, glucose, kidney function, and proteins.

Functional measures

Grip strength, gait speed, VO2 max, and body composition often predict outcomes better than a single lab marker.

What they can tell you

• Risk trends over time
• Whether an intervention changes a biomarker
• How your biology compares with population averages

What they cannot tell you

• Your exact future lifespan
• Whether one supplement has truly reversed aging
• A complete picture from one sample

diagram

note

Why epigenetic clocks matter

In 2013, Steve Horvath published a multi-tissue DNA methylation clock in Genome Biology. It was a major step because it suggested that aging leaves a measurable chemical signature.

Later clocks improved prediction of disease and mortality. GrimAge, published in 2019, was especially strong for mortality risk prediction. That does not mean it is a magic aging meter. It means it is a useful proxy.

A proxy is not the thing itself. A weather app is not the sky. It helps you decide whether to carry an umbrella.

illustration

chart · bar

Examples of longevity markers

3. Senolytics, rapamycin, and the real state of anti-aging drugs

4. Evidence-based longevity protocols that actually move the needle

5. How to think like a longevity scientist

Transcript

Welcome to Slate. Today we're looking at Can You Reverse Aging? The Science of Longevity. We'll cover Lifespan vs. healthspan — why the distinction matters, Biological age testing and what it reveals, Senolytics, rapamycin, and the science behind them, and Evidence-based lifestyle protocols for longevity. Let's get into it.

Aging is not one clock. It is several processes moving at different speeds. Lifespan is how long you live. Healthspan is how long you stay functionally well. Two people can both reach 80. One may still walk, think, and recover quickly. The other may spend the last 15 years managing frailty, diabetes, and heart disease. That gap is the real target of longevity science. Here is the core idea. Aging is the gradual loss of resilience. Like a house that still stands but needs more repairs after every storm, the body can keep going while its repair systems get slower and less accurate. Damage accumulates in DNA, proteins, mitochondria, and tissues. Cells also change how they communicate. Some become senescent, meaning they stop dividing but do not die. They can release inflammatory signals that affect nearby cells. Scientists often describe aging through the Hallmarks of Aging framework, first proposed in 2013 by Carlos López-Otín and colleagues. It includes genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication. That list matters because it shows aging is biological, not mystical. The practical question is not whether we can stop aging. We cannot, at least not with current evidence. The real question is whether we can slow damage, improve repair, and extend healthspan. That is where the strongest data live.

Chronological age is your birthday count. Biological age tries to estimate how old your body seems compared with that count. Here is the important part: no single test captures the whole story. Aging shows up differently in blood, DNA marks, inflammation, and function. The most discussed tools are epigenetic clocks. These use patterns of DNA methylation, which are chemical tags that help control gene activity. Steve Horvath’s 2013 clock was a landmark because it predicted age across many tissues with surprising accuracy. Later clocks, such as PhenoAge and GrimAge, were built to predict health outcomes, not just birthdays. That makes them more useful for risk, but still not a full measure of aging. A biological age test is a bit like checking a car with one sensor. Odometer, engine temperature, tire wear, and fuel efficiency each tell part of the story. No single reading tells you whether the car is safe on a long trip. That is why a good longevity plan uses multiple layers. Blood pressure, ApoB, fasting glucose, HbA1c, body composition, grip strength, cardiorespiratory fitness, and sleep all add context. A test result is useful only if it changes decisions. If it does not guide an intervention, it is mostly curiosity. The most honest interpretation of these tests is this: they are promising research tools and useful trend markers, but they are not yet validated as stand-alone proof that you have reversed aging.

This is where longevity science gets exciting and easy to oversell. Senolytics are drugs designed to clear senescent cells. Rapamycin is a compound that inhibits mTOR, the mechanistic target of rapamycin, a nutrient-sensing pathway tied to growth and maintenance. In mice, both approaches can extend healthy life in some settings. That is real science. But mice are not small humans. The dose, timing, tissue effects, and side effects can be very different in people. Senolytics have included dasatinib plus quercetin, fisetin, and other candidates. Early human studies are small. For example, pilot trials have explored safety and biomarker changes in diseases such as idiopathic pulmonary fibrosis and diabetic kidney disease. Those are encouraging signals, not proof of broad anti-aging benefit. Rapamycin is even more interesting. In mice, it extends lifespan in multiple studies, including work from the National Institute on Aging Interventions Testing Program. In humans, it is approved as an immunosuppressant and for certain cancers and transplant settings. Low-dose or intermittent use for longevity is still off-label and not established by large randomized trials. The key lesson is this: biology can point to plausible targets, but plausibility is not enough. A drug that changes a pathway in cells may still fail in humans because of toxicity, narrow benefit, or poor trial design. Longevity medicine is still in the evidence-building stage.

The most reliable longevity protocol is not exotic. It is boring in the best possible way. The goal is to reduce the big drivers of early death and late-life disability: cardiovascular disease, cancer, diabetes, falls, dementia, and frailty. Exercise is the strongest intervention you can control. Resistance training preserves muscle. Aerobic training improves cardiorespiratory fitness, which is one of the best predictors of mortality. In older adults, even modest strength gains can improve balance and independence. Think of muscle as your metabolic savings account. When you lose it, every illness becomes harder to recover from. Nutrition matters most when it helps you maintain a healthy body composition and cardiometabolic profile. A Mediterranean-style pattern has strong evidence for cardiovascular benefit. Protein intake matters more with age because muscle protein synthesis becomes less responsive. Sleep matters because short sleep worsens glucose control, appetite regulation, and blood pressure. The medical side is just as important. Control blood pressure. Lower ApoB if it is elevated. Screen for diabetes. Treat sleep apnea. Vaccinate. Stop smoking. These steps have much stronger evidence than most supplements. Supplements are the weak link in the longevity market. Some may help in specific deficiencies. Most do not reverse aging. If a protocol does not improve measurable health markers, it is not an evidence-based protocol. It is a hope-based one.

Longevity science is moving from slogans to measurement. That is good news. It also means you need a sharp filter. Ask three questions about any intervention. First, what is the target? A biomarker, a symptom, a disease, or survival? Second, what is the evidence in humans, not just in cells or mice? Third, what is the tradeoff? Every intervention has costs, whether financial, biological, or behavioral. The most honest view is that we do not yet have a proven way to reverse human aging in a general sense. We do have ways to slow the diseases that make people old before their time. We also have promising tools for measuring biological aging and testing future therapies. If you remember one thing, remember this. The best longevity strategy today is a layered one. Use biomarkers to guide action. Use exercise, sleep, nutrition, and risk-factor control as the base. Treat senolytics, rapamycin, and other experimental approaches as research questions until strong human evidence says otherwise. That is how the field should work: careful, measurable, and useful. Not immortal. Just better aging.